Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands

Arch Dermatol. 2009 Mar;145(3):334; author reply 335. doi: 10.1001/archdermatol.2008.620.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • CREST Syndrome / complications
  • Calcinosis / drug therapy*
  • Calcinosis / pathology
  • Dermatomyositis / complications
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Skin Diseases / drug therapy*
  • Skin Diseases / pathology

Substances

  • Immunoglobulins, Intravenous